The bovine immunodeficiency-like virus (BIV) is an infectious retrovirus and a unique member of the lentivirus subgroup of retroviruses, which also includes human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2, respectively) (12, 16, 17) . BIV, like the primate lentiviruses, possesses a complex genome with at least five putative accessory genes (6, 7, 12, 16, 20, 22, 30, 31) . The accessory genes of lentiviruses play a significant role in regulating virus gene expression and may also be involved directly or indirectly in their in vivo pathogenesis (6, 7, (20) (21) (22) .
BIV was originally isolated from a cow with persistent lymphocytosis, lymphadenopathy, central nervous system lesions, weakness, and emaciation; experimental inoculation of specific-pathogen-free calves with tissue culture-propagated BIV induces a mild, persistent lymphocytosis and lymphadenopathy (5, 39) . Seroprevalence studies suggest that BIV is sporadically present in cattle populations in the United States (15) . BIV is most efficiently transmitted via infected blood and cell-free and cell-associated tissue culture-derived virus; calves experimentally inoculated with BIV appear to become chronically infected and mount a virus-specific humoral response (5, 32, 39, 41) . Little else is known about the biology of experimental and natural BIV infections, including BIV's role in bovine disease and the host's immune response to BIV infection.
A unifying feature of lentiviruses is the ability to replicate in, and cause chronic infection of, immune system cells; the usual targets are monocytes/macrophages and lymphocytes (11, 13, 14, 19, 27) . In many cases, the virus may remain latent in individual cells for long periods of time, although virus replication in the organism is probably continuous. The fact that lentiviruses are retroviruses, and thus can integrate into the host genome, largely accounts for their persistence. In this regard, cellular as well as viral factors may be * Corresponding author. responsible for regulating virus gene expression and replication (6, 7, 20) .
We are interested in developing a BIV-small-animal model that may be useful in studying mechanisms of lentivirus persistence and methods of intervention relevant to HIV-1 infections. The host range of lentiviruses is normally restricted to the natural host and closely related species (19, 29) . In the process of characterizing the in vitro and in vivo host range of BIV, we found that the virus can replicate efficiently in cells of rabbit as well as bovine origin. In light of this observation, we attempted to infect rabbits with BIV in vivo. We inoculated specific-pathogen-free juvenile New Zealand White rabbits (Otyctolagus cuniculus) with either a natural isolate or progeny of a proviral molecular clone of BIV; as shown below, all became chronically infected. Virus replication and the host's humoral immune response to BIV were studied in these animals for up to 2 years.
For in vitro and in vivo studies of BIV infection, two different BIV stocks, BIVPar, produced from cells infected with the original isolate of BIV (39) , and BIV127, produced from cells transfected with a functional molecular clone of BIV (3), were used to inoculate the rabbits. Virus stocks were propagated in either bovine leukocyte adherent (BLAC-20) or embryonic rabbit epidermal (EREp) cells. EREp cells were obtained from the American Type Culture Collection (catalog no. CRL 6498). BLAC-20 cells were derived from the long-term culture of Ficoll-Hypaque-separated bovine peripheral blood leukocytes (PBLs) obtained from a BIV-and bovine leukosis virus-negative calf. The cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum and antibiotics. Phytohemagglutinin at 1 ,Lg/ml was included in the culture medium during the first 48 h, and human interleukin-2 (Collaborative Research) at 500 U/ml was included for the following 14 days. These cultures, which contained adherent cells with the morphology of monocytes/macrophages, were trypsinized when confluent and replated in the original flask in Dulbecco's modified Eagle's high-glucose medium (DMEM) containing 10% fetal (34) . The serologic responses of rabbits to BIV were analyzed by using denatured recombinant BIV Pr539'ag separated on 13% polyacrylamide gels, and transferred to Immobilon. BIV antigen strips were immunostained with sequential bleeds from rabbits inoculated with either BIV-infected or uninfected cells; bound antibody was visualized by using the immunoperoxidase enzyme method and a precipitable substrate (34, 35 were considered negative if syncytia had not appeared. Cells from the virus rescue cocultures were analyzed by thinsection electron microscopy as previously described (18) . Tissue samples (2 mm3) for PCR were taken at necropsy and processed for genomic DNA. The DNA was resuspended in sterile H20 and sonicated for 15 min. Synthetic oligomers (GTCTCTGTTGGTACCCGTTA and CATATGGGACAA CAACAATGTGGACAG) selected from the central region of the BIV genome (nucleotides 5091 to 5110 and 5364 to 5338, respectively) (12) were used for the PCR amplification of BIV sequences in rabbit tissue DNA, using components of a Gene-Amp kit (Perkin-Elmer Cetus). PCR products were fractionated on 1% agarose gels and transferred to GeneScreen Plus (Du Pont-NEN) for hybridization using a 32p_ labeled, gel-purified, PCR-generated probe representing nucleotides 5091 to 5364 of BIV127 (12), using conventional molecular biology methods (36) . BIV-specific PCR products were visualized by autoradiography. Tissue samples from most major organs were taken at necropsy, fixed in formalin, and embedded in paraffin; sections were stained with hematoxylin and eosin for histopathologic examination. For immunohistochemical staining, embedded tissue sections from both infected and uninfected animals were cut and deparaffinized. These tissue sections were immunostained with a polyclonal rat antiserum to recombinant BIV Pr53"ag (34) or a normal rat antiserum and the avidin-biotin peroxidase-complex immunohistochemical technique (40), using a Vectastain anti-rat immunoglobulin G (IgG) kit according to the recommendations of the manufacturer (Vector Laboratories). Immunostained slides were counterstained with hematoxylin.
Since we established that BIV could grow in rabbit cells, we wanted to determine whether BIV would replicate in rabbits. Rabbits were inoculated with a single dose of 107 BIVPar_ or BIV127-infected BLAC-20 or EREp cells. The animals were monitored for a humoral response to the infection by ELISA (Fig. 1A) . Of the 10 animals that were given a BIV-infected inoculum, the majority convincingly seroconverted to BIV by 2 weeks postinoculation, while the others took up to 6 weeks; none of the animals that were given uninfected EREp or BLAC-20 cells seroconverted to BIV. There appeared to be no significant difference in the antibody response obtained with either the BIVpar or BIV127 inoculum or whether the viruses were propagated in EREp or BLAC-20 cells. The BIV-specific antibody response increased over time (Fig. 1A) , with maximum ELISA titers of 1:25,000 (data not shown). This strong immunologic response persisted until the animals were euthanized; for two animals, this was a period of 22 months. IgM and IgG antibody responses were also measured. By 2 weeks postinoculation, it appeared that the IgM response had already subsided, in that no BIV-specific IgM was detectable by ELISA (data not shown); sera were not taken at earlier time points. A similar early decline in IgM antibodies has been shown in animals infected with other viruses (33) . We used a sensitive Western immunoblot assay using recombinant BIV Gag precursor (Pr53Yag) made in the baculovirus-insect cell expression system (34) to detect early seroconversion to BIV and to confirm the ELISA results. All animals inoculated with BIV seroconverted specifically to BIV Pr53gag between 2 and 4 weeks postinoculation; the relative strength of the antibody response rose rapidly before appearing to level off as in the ELISA, although absolute antibody titers to Pr53fag were not determined (Fig. 1B) c Tissues cocultured in the first virus rescue attempt but which had to be omitted in later attempts because of the logistics of handling large numbers of cocultures or the lack of sufficient tissue. (Fig. 1B) . Nevertheless, virus was rescued from the spleens of both animals. BIV DNA sequences were also demonstrated by PCR in the small intestine, peritoneal wash, and omentum of rabbit E (no spleen was available for testing) and the spleen, bone marrow, peritoneal wash, and lymph nodes of rabbit H. The serologic results in Fig. 1 demonstrate that antibodies directed to epitopes on the BIV Gag precursor are an early and positive indicator of seroconversion, and the retention of a strong antibody response to Gag over time is indicative of active virus replication; the contribution of Env antibodies to the humoral response over time has not been studied in this investigation but may differ from that of Gag.
By using sera obtained from terminal bleeds, the serologic response of BIV-infected rabbits was determined in Western blots and immunoprecipitations and was compared with the reactivity of serum from a naturally infected bovine (Fig. 2) . In the immunoblots using BIV virions, bands corresponding to the envelope precursor and surface (SU) glycoproteins, gPrl45 and gplOO, respectively, and the Gag precursor, capsid (CA), matrix (MA), and nucleocapsid (NC) proteins, Pr53gag, p26, p16, and p13, respectively (2, 26), were observed, as well as several virus-specific bands whose identity has not been established ( Fig. 2A) . Radioimmunoprecipitation of BIV-infected cell and virion lysates showed that gplOO SU, Pr53gag, p26 CA, and p16 MA proteins were immunoprecipitated by the BIV-infected rabbit sera (Fig.  2B) . Recombinant Pr53gag and Env proteins synthesized in the baculovirus-insect cell expression system (34, 35) were also immunoprecipitated by the BIV-infected rabbit sera (Fig. 2B) , further substantiating the specificity of the rabbit humoral response to authentic BIV Gag and Env proteins. In Western blots and immunoprecipitations, the recognition of native and recombinant BIV Gag and Env structural proteins by antibodies in BIV-infected rabbits was similar to that of BIV-infected bovines (32, 34, 35) . As expected, the sera from rabbits inoculated with uninfected EREp or BLAC-20 cells did not detect any BIV-specific bands in either the Western blots or immunoprecipitations. Virus rescues were attempted on individual animals that were euthanized at 1, 5, 7, and 9 months postinoculation and two animals each at 2, 17, and 22 months postinoculation. In all cases, BIV was successfully rescued from the spleens, lymph nodes, or PBLs of BIV-infected rabbits by cocultivation with BESp cells; the tissues of one animal were not available for study (Table 1) . In most cases, syncytia, indicative of virus infection, were apparent in the BESp cells after the first subculture (day 4) (Fig. 3B ). Syncytia were never observed in BESp cells that had been cocultured with tissues from rabbits inoculated with uninfected BLAC -20 or EREp cells or other organs of BIV-infected rabbits (Fig.  3A) . In some infected animals, successful virus rescues were made periodically from PBLs in the interval between initiation of infection and euthanasia of the animal. The specific induction of syncytia in BESp cocultures with infected tissues (but not uninfected tissues), the positive reverse transcriptase results with supernatants from cultures containing syncytia, and the identification by electron microscopy of virus particles with a typical lentivirus morphology (Fig. 3C) all indicated that the virus rescued was BIV. In all instances, the presence of BIV was confirmed by specific PCR amplification of BIV sequences in the DNA of cells used in the coculture (data not shown). We wanted to determine whether BIV sequences could be detected in the DNA extracted directly from tissues of BIV-infected rabbits, which may be further indicative of the tropism of the infection. As shown in Table 1 , BIV sequences were most frequently detected in the lymph nodes, spleen, peritoneal wash (presumably containing macrophages), and bone marrow. PBL DNAs were not tested. Tissues from animals given uninfected cells were negative for BIV sequences by PCR analysis (data not shown). Our ability to readily rescue virus from spleen, lymph nodes, and PBLs, as well as the positive PCR results, suggested that these tissues may be the sites of active virus replication. Immunohistochemical staining of tissue samples from various organs of several animals was performed by using a rat anti-Pr53gag or normal rat serum to localize BIV-specific antigens. Antigen-positive cells were detected only in the red pulp of the spleen of infected animals with the rat anti-Pr539'9 serum (Fig. 4A) ; no BIV-specific staining was observed with the control normal rat serum or in tissues from uninfected rabbits (data not shown). The BIV antigen-containing mononuclear cells in the infected animals appeared to be of the macrophage lineage and were atypical and blastic (Fig. 4B) .
All rabbits experimentally infected with BIV appeared clinically normal throughout the experiment, and differential and total leukocyte counts remained within normal ranges for both infected and uninfected animals (data not shown). BIV-infected and uninfected animals (as controls) were euthanized at various time points and examined for gross pathologic lesions at necropsy. The only differences noted between infected and uninfected animals were the slight enlargement of lymph nodes and spleen in the infected animals terminated 5 and 7 months postinoculation. Histopathologic examinations of major organs of animals terminated prior to 9 months revealed subtle and inconsistent lesions which included multifocal lymphoreticular infiltrates in the lungs, moderate depletion of T-cell regions of the white pulp of the spleen, and multinucleated giant cells in the omentum.
Rabbit cells and the laboratory rabbit have been experimentally infected with several types of retroviruses, including bovine leukosis virus, HIV-1, and human T-cell leukemia virus type I (HTLV-I) (1, 4, 8, 9, (23) (24) (25) 28) . The HTLV-I infection in the rabbit has no associated disease or lesions, but it has been used as a model for HTLV-I transmission and vaccination studies (38) . In the present study, the infection of rabbits with BIV derived from bovine or rabbit cells was accomplished with a single intraperitoneal dose of 107 infected cells, although we have since shown that a single dose of 104 BIV-infected cells given intraperitoneally is sufficient to induce a persistent infection in rabbits (32) . HIV-1 is the only other lentivirus that has been shown to replicate in rabbits (8, 9, 23, 25) . The BIV infection of rabbits results in a rapid (within 2 weeks of inoculation), high-titered (ELISA titers of up to 1:25,000), and sustained (up to 22 months postinoculation) humoral response and the reliable rescue of virus from immune organs or tissues. The serologic results with BIV are in contrast to those reported for the HIV-1 infection of rabbits, in which antibody titers in ELISA are lower (1:2,560), peak at approximately 3 months postinoculation, and steadily decline (1:320) thereafter (8, 9) .
In this study, BIV was rescued from 100% of the rabbits receiving infectious inoculum; virus was also rescued from various tissues of the immune system, including spleen, lymph nodes, and PBLs. By using PCR amplification, BIV DNA sequences were found primarily in the same tissues from which virus was rescued, but they were also found in the bone marrow and brain. Immunohistochemistry with BIV-specific antisera localized BIV antigens in mononuclear cells of the red pulp of the spleen. Taken together, these results suggest that BIV replicates in cells of the immune system, possibly monocytes and macrophages. The fact that BIV can be rescued from infected animals persistently producing BIV-specific antibodies provides direct evidence that the BIV infection is chronic and is not overcome by the host's immune system. The contribution of neutralizing antibodies and cellular immunity to the host defense against BIV infection has not been addressed, but the failure to clear the virus suggests that the virus-specific humoral response, and also possibly the cellular response, may be deficient. Additional studies on the virus-specific humoral and cellular immune responses in BIV-infected animals are in progress.
The lack of overt disease in the BIV-and HIV-1-infected rabbits may be analogous to HIV-1 infection of chimpanzees (10) . The reasons for the lack of clinical disease in BIV infections of rabbits are not known, but several explanations can be proposed. First, the BlVpar isolate, and progeny from proviral molecular clones, may be attenuated; BIVpar has been in culture for over 20 years and shows a strong tropism for adherent embryonic bovine cells, which may not be typical of the tropism of new field isolates of BIV (32) . Significant lesions and disease development may take longer than 2 years to occur. It is also possible that the rabbit immune response offers protection from disease but not from infection. The possibility also exists that BIV does not directly cause severe lesions in the tissues in which it replicates, but may exert its effects on the immune system in a more subtle way, perhaps through mild immunosuppressive activity. Although BIV has not been demonstrated to cause any immune system dysfunction or blood cell disorder, BIV sequences were found in the bone marrow of infected rabbits by PCR amplification. There was also a subtle depletion of cells in the T-cell regions of the white pulp of spleens in infected animals. HIV-1 has also been demonstrated to infect bone marrow cells in vitro, as well as CD4+ cells, and to cause in vitro suppression of bone marrow progenitor cells (37) . Finally, adventitious agents may be required to potentiate BIV's effects. The specificpathogen-free New Zealand White rabbits used in this study were maintained in a barrier facility and therefore were not subjected to normal rabbit pathogens.
Although much information still needs to be gathered, our studies suggest that the chronic infection of rabbits with BIV may be a useful lentivirus-animal model with a number of advantages. Laboratory rabbits are small, inexpensive, and readily available. BIV causes chronic infections in the rabbit immune system. BIV is a lentivirus with a genome complexity that closely correlates with that of the primate and human lentiviruses, but it does not appear to infect humans or cells of human origin (12, 15) . This model should offer the opportunity to test novel prophylactic and therapeutic measures of relevance to HIV-1 as well as the opportunity to study mechanisms of lentivirus persistence and replication.
